Brief: Abbvie And Gubra Announce License Agreement
March 3 (Reuters) - Gubra A/S GUBRA.CO: ABBVIE AND GUBRA ANNOUNCE LICENSE AGREEMENT TO DEVELOP AN AMYLIN ANALOG FOR THE TREATMENT OF OBESITY Source text: ID:nMFN9ytvFw Further company coverage: GUBRA.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))